PharmaCielo draws $2.5M from insider bridge loan to keep operations afloat
What's the deal? PharmaCielo, a Canadian-listed cannabis company with cultivation operations in Colombia, has drawn roughly US$1.83M from a US$2.2M insider bridge loan facility to fund its working capital since February 2024. The company also issued 11,145,999 common shares at US$0.06 each to cover US$653.9K in semi-annual interest on its 11% secured debentures — effectively paying debt interest with equity instead of cash.
The TSX Venture Exchange approved the shares-for-debt transaction, which qualifies as a related-party deal under Canadian securities rules. PharmaCielo said the financing has supported ongoing operations and cost-reduction efforts.
Why now? The company has relied primarily on the insider bridge facility for working capital for over a year. Issuing shares to satisfy interest payments signals PharmaCielo is conserving whatever cash it has left, a common survival tactic for capital-constrained firms.
What could go wrong? The risks are stacking up. Issuing more than 11 million new shares dilutes existing shareholders, and the 11% interest rate on both the debentures and the bridge loan is steep — a sign that outside lenders aren't exactly lining up to extend credit.
Relying on insiders for financing can buy time, but it also raises governance questions. Related-party transactions, even when exchange-approved, deserve scrutiny. And if the company can't generate enough revenue to service its debt without printing more shares, the dilution cycle could continue.
The signal: PharmaCielo's reliance on insider bridge financing and equity-for-debt swaps underscores the persistent funding drought facing smaller, internationally focused cannabis operators. With the company classified as "breakout" stage yet still unable to access external capital markets, its predicament illustrates how far investor sentiment has swung from the sector's 2021 highs — and how narrow the survival corridor has become for cannabis firms that haven't yet reached self-sustaining cash flow.
Read more: stocktitan.net
